NCT04988178View on ClinicalTrials.gov

Analysis of naïve Patients With Age-related Macular Degeneration Neovascular Type and Treated With Ranibizumab (Lucentis®) in Treat-and-extend at the CHU Brugmann.

CompletedOBSERVATIONAL
Enrollment

34

Participants

Timeline

Start Date

April 13, 2021

Primary Completion Date

September 22, 2021

Study Completion Date

September 22, 2021

Conditions
Macular Degeneration
Interventions
OTHER

Data extraction from medical files

Data extraction from medical files

Trial Locations (1)

1020

CHU Brugmann, Brussels

All Listed Sponsors
lead

Brugmann University Hospital

OTHER